Outlook Therapeutics
OTLK
OTLK
87 hedge funds and large institutions have $12M invested in Outlook Therapeutics in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.05% more ownership
Funds ownership: 0.53% → 0.58% (+0.05%)
Holders
87
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$383K | |
| 2 | +$340K | |
| 3 | +$109K | |
| 4 |
Millennium Management
New York
|
+$109K |
| 5 |
Barclays
London,
United Kingdom
|
+$74.4K |
Top Sellers
| 1 | -$172K | |
| 2 | -$101K | |
| 3 | -$57K | |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$23.6K |
| 5 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$21.4K |